Hematology-Oncology Clinics of North America

Papers
(The median citation count of Hematology-Oncology Clinics of North America is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Chronic Lymphocytic Leukemia93
Contents62
Forthcoming Issues56
Forthcoming Issues45
Contributors44
Conflict and Access to Health Care33
The New Science and Concepts That Underlie Current and Future Treatments for Myeloproliferative Neoplasms31
The Emerging Potential of Lead-212 Theranostics29
Patient, Caregiver, and Provider Well-Being in Oncology27
Forthcoming Issues27
FLASH Radiotherapy27
Cancer of the Larynx and Hypopharynx25
Future Directions in Bladder Cancer Treatment and Research—The Patient Advocates’ Perspective24
Autoimmune Hemolytic Anemia: An Old Disease with New Twists23
Contributors22
Is There a Role for Immunotherapy in Central Nervous System Cancers?20
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors20
Clinical Complications and Their Management20
Subspecialty Breast Imaging Education in Tanzania; Clinical, Infrastructure, and Logistical Paradigms for Best Practices in the Low- and Middle-Income Settings19
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia19
Nonsurgical Therapy for Early-Stage Lung Cancer19
Copyright19
Education and Training Models for Remote Learning18
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma18
Copyright17
Managing First-Line Metastatic Renal Cell Carcinoma17
Contents16
Forthcoming Issues16
Copyright16
New Therapies on the Horizon15
Copyright15
Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer15
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases14
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia14
Copyright13
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies13
Contributors13
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers13
Forthcoming Issues12
Treatment of High-Risk Gestational Trophoblastic Neoplasia12
Copyright12
Contributors11
Copyright11
Central Nervous System Complications Among Oncology Patients11
Forthcoming Issues11
Insights into Renal Cell Carcinoma with Novel Imaging Approaches10
Accelerated and Blast Phase Myeloproliferative Neoplasms10
Hemophilia A (Factor VIII Deficiency)10
Biology and Treatment of HER2-Low Breast Cancer10
Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors10
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver10
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia10
Surgical Management of Breast Cancer Liver Metastasis9
Surgical Management of Gestational Trophoblastic Neoplasia9
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?9
Management of Metastatic Liver Tumors9
Prognostic and Predictive Implications of Cytogenetics and Genomics9
Real World Outcomes of Patients with Bladder Cancer9
Forthcoming Issues9
Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies?9
Early Detection and Interception of Lung Cancer8
Hemophilia A/B8
State of Cancer Control in South America8
Targeted Therapy for Non–Small Cell Lung Cancer8
The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies8
Approach to the Patient with Bleeding8
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?8
Murine Modeling of Myeloproliferative Neoplasms8
Clinical Vignettes, Part II: Eyes, Teeth, and Bone8
A Curative DNA Code for Hematopoietic Defects8
The Cardiopulmonary Complications of Sickle Cell Disease8
Toxicity Management of Systemic Kidney Cancer Therapies8
Current Clinical Investigations in Myelofibrosis7
Targeted Therapy Innovations for Melanoma7
Erratum7
Ductal Carcinoma In Situ7
What Is New in Small Cell Lung Cancer7
Genetic Modifiers of Sickle Cell Disease7
Prognostic Models in Metastatic Renal Cell Carcinoma7
Molecular Biology of Bladder Cancer7
Structural Racism and Impact on Sickle Cell Disease7
Disorders of Fibrinogen and Fibrinolysis6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma6
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis6
Early and Late Toxicities of Chimeric Antigen Receptor T-Cells6
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors6
The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes6
Screening for Colorectal Cancer6
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy5
Thalassemia5
Preface5
Central Nervous System Malignancies5
Contents5
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer5
Gene Therapy for Pediatric Neurologic Disease5
Advancing Effective Clinical Trial Designs for Myelofibrosis5
Current Perioperative Therapy for Muscle Invasive Bladder Cancer5
Contributors5
Copyright5
Impact of Clonal Heterogeneity in Multiple Myeloma5
Contributors5
Contributors5
Forthcoming Issues5
Contents5
Surgery for Bladder and Upper Tract Urothelial Cancer4
Colorectal Cancer4
Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal Cancer4
Contents4
Copyright4
Contents4
Important Pathologic Considerations for Establishing the Diagnosis of Myelofibrosis4
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer4
Hematology/Oncology Clinics of North America4
CAR T-Cell4
Emerging Paradigms in Radiation Oncology: Treatment Evolution, Mechanisms, and Patient Centric Care4
Contents4
Dedication4
Contributors4
Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia4
Contents4
Advances and Opportunities in the Management of Lung Cancer4
Laboratory Methods in the Assessment of Hereditary Hemostatic Disorders4
Role of Surgery in Metastatic Renal Cell Carcinoma4
Contributors4
Updates in the Management of Warm Autoimmune Hemolytic Anemia4
Central Nervous System Tumor Classification4
Copyright4
Chronic Pain3
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art3
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia3
Surgical Management of Genitourinary Cancer Liver Metastases3
The Epidemiology of Bladder Cancer3
Benefits and Harms of Interception and Early Detection of Cancer3
Early Detection of Precursor Diseases of Multiple Myeloma3
Cancer Precursor Syndromes and Their Detection in the Head and Neck3
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes3
Traipsing Through Muddy Waters3
Genetics and Genomics of Gestational Trophoblastic Disease3
75 Years of Advancement in Gestational Trophoblastic Disease3
Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution3
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer3
Pathogenic Mechanisms in Thalassemia I3
Contributors3
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer3
The Role of Megakaryocytes in Myelofibrosis3
Merkel Cell Carcinoma3
Diagnosis and Management of Molar Pregnancies3
Advances in Adjuvant and Neoadjuvant Therapy for Melanoma3
Forthcoming Issues3
Metastatic Liver Tumors: The Path to Disease-Free Survival3
Inherited Bleeding Disorders2
Molecular Pathogenesis of Multiple Myeloma2
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma2
Forthcoming Issues2
Disparities in Breast Cancer Outcomes and How to Resolve Them2
Contents2
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia2
Myeloproliferative Neoplasms2
Adult Evans' Syndrome2
Approach to High-Risk Multiple Myeloma2
Fetal Hemoglobin Regulation in Beta-Thalassemia2
Factor XIII Deficiency2
Neurofibromatoses2
Management of Waldenström Macroglobulinemia in Limited-Resource Settings2
The Microenvironment in Myeloproliferative Neoplasms2
Immunotherapy-associated Autoimmune Hemolytic Anemia2
Management of Rectal Cancer2
Future Directions for Gestational Trophoblastic Disease2
Renal Cell Cancer2
Chronic Lymphocytic Leukemia: So Much Progress, Still Challenges Ahead2
Management of Bladder Cancer: The First Inning of a New Era of Rapid Advances2
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia2
Diagnostic Accuracy of Biomarkers and International Ovarian Tumor Analysis Simple Rules in Diagnosis of Ovarian Cancer2
Immune-Pathogenesis of Myeloma2
Microbiome and Immunotherapy for Melanoma2
Overview of Myeloproliferative Neoplasms2
New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma2
Genome-Edited T Cell Therapies2
Hematopoietic Stem Cell Transplantation in Thalassemia2
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma2
Foreword2
Advances in Gastric Cancer Surgical Management2
Copyright2
Contributors2
Advances in Immunotherapy in Esophagogastric Cancer2
Contents2
Inherited Bleeding Disorders2
The Evolving Landscape of Drug Therapies for Sickle Cell Disease2
Pathogenic Mechanisms in Thalassemia II2
Measurable Residual Disease and Decision-Making in Multiple Myeloma2
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis2
Immune Therapy for Chronic Lymphocytic Leukemia1
Quality of Life in Myeloproliferative Neoplasms1
Novel Targeted Therapies for Renal Cell Carcinoma1
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)1
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies1
Cancer of the Oropharynx and the Association with Human Papillomavirus1
Targeted Agents in Esophagogastric Cancer Beyond Human Epidermal Growth Factor Receptor-21
Copyright1
The Gut Microbiome in Colorectal Cancer1
Lip and Oral Cavity Squamous Cell Carcinoma1
The Proimmunomodulatory and Anti-immunomodulatory Effects of Radiotherapy in Oncologic Care1
Immunotherapy and Immunomodulation in Myeloproliferative Neoplasms1
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas1
Contributors1
Copyright1
Advances in Surgical Techniques for Lung Cancer1
Nevi and Melanoma1
The Need for Translational Epidemiology in Beta Thalassemia Syndromes1
Thalassemia1
Inequity in Cancer and Cancer Care Delivery in the United States1
Primary Central Nervous System Lymphomas1
The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia1
Histiocytic Disorders in Pediatric and Adult Patients1
Intraarterial Chemotherapy for Liver Metastases1
Local Therapies in Advanced Colorectal Cancer1
Forthcoming Issues1
Artificial Intelligence, Machine Learning and Big Data in Radiation Oncology1
Advances in Systemic Therapy in Pancreatic Cancer1
Complications of Autoimmune Hemolytic Anemia1
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia1
Remembering the Contributions of Professor David J. Weatherall1
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors1
Immunotherapy1
Genetics of Pancreatic Neuroendocrine Tumors1
Acquired von Willebrand Syndrome1
Current Therapy for Metastatic Urothelial Carcinoma1
Factor XI Deficiency1
Gene Therapy for Inborn Errors of Immunity1
Preclinical Models for Bladder Cancer Research1
Inherited Platelet Disorders1
Macrophage Activation Syndrome1
First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma1
Gene Therapy and Gene Editing for β-Thalassemia1
Impact of Social Media on Oncology Care1
Salivary Gland Cancers1
Evidence-Based Guidance for Breast Cancer Survivorship1
Emerging Therapies in β-Thalassemia1
Genomic Alterations in Langerhans Cell Histiocytosis1
Forthcoming Issues1
Esophagogastric Cancer1
Contents1
Ultra High-risk Gestational Trophoblastic Neoplasia0
Contents0
Contributors0
GTN Diagnosis and Staging0
Breast Cancer0
Contents0
An Overview of Liver Directed Locoregional Therapies0
Copyright0
0.33113884925842